Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

FPC Capital Requirements

20 Jun 2013 07:08

RNS Number : 4621H
Royal Bank of Scotland Group PLC
20 June 2013
 



 

 

The Royal Bank of Scotland Group plc

 

20 June 2013

 

Statement on the completion of the UK Regulators capital shortfall exercise

 

The Royal Bank of Scotland Group plc ("RBS", "the Group") notes today's announcement by the Prudential Regulatory Authority ("PRA") on the completion of its capital shortfall exercise across major UK banks and building societies.

 

As indicated in its earlier release, dated 22 May, RBS expects to continue to improve its Core Tier 1 capital ("CT1") ratio during 2013 through continued delivery against its established business plan.

 

RBS continues to target a 'fully loaded' Basel 3 CT1 ratio of around 9% by year end 2013, after including the provision of capital to fund anticipated future loan growth.

 

Further details of RBS's plans and a reconciliation to the results published by the PRA today are provided below in the Appendix to this announcement.

 

For further information contact:

 

RBS Group Investor Relations

Richard O'Connor

Head of Investor Relations

+44 207 672 1758

RBS Group Media Relations

Michael Strachan

Deputy Head of Group Media Relations

+44 131 523 4205

 

Appendix to statement:

Reconciliation with RBS Group plc published ratios and 2013 glidepath

 

The PRA's original assessment of RBS's capital adequacy, under the FPC's recommendations, is outlined in the table below. RBS's position, factoring in business plans and actions announced at the FY12 results and Q113 IMS, is presented alongside this.

RBS's position takes into account the Group's previously announced repositioning of its Markets business and the planned continued reduction of Non-Core exposures, as well as other actions. While the Group's intention to partially IPO Citizens was announced in consideration of the PRA capital exercise, it is not factored into the 2013 capital actions.

The principal adjustments that RBS applied to the PRA December 2012 start point are:

1) the RBS assumption around counterparty credit model acceptance that a) brings RBS in line with peers and b) has been worked on for two years, with acceptance expected prior to CRDIV implementation at the start of 2014;

2) Latest Capital Requirements Directive IV ("CRDIV") changes, which exempt EU corporates, pension funds and sovereign exposures from CVA volatility charge, confirmation of which was announced post the original PRA analysis.

By the end of 2013, the PRA capital requirement under the FPC exercise of £3.2bn is targeted to be reduced to £0.4bn. Several actions contribute to this including Markets downsizing, several small planned divestments and LME gains.

 

 

 

 

 

RBS capital requirements compared to PRA view

Reference

Per PRA

RBS

 

£bn

£bn

End 2012 position

Core Capital Resources (CET1 Basel 3)

37.2

Reported RWAs (Basel 3)

567.9

End 2012 CET1 Ratio

6.5%

Known capital adjustments

Note 2

1.0

Known/expected RWA adjustments

Note 3

(72.9)

Core Capital Resources (CET1 Basel 3)

38.2

Reported RWAs (Basel 3)

495.0

CET1 Ratio (as published by RBS)

Note 1

7.7%

PRA adjustments

PRA adjustments to capital resources for expected future losses and an assessment of future cost of conduct redress

(7.1)

(7.1)

PRA adjustments to RWAs to reflect a more prudent calculation of risk weights

56.3

56.3

Capital actions

Total CET1 equivalent of capital actions required of RBS

13.6

7.5

CET1 equivalent actions in RBS's plans

10.4

7.1

Additional capital action requirement planned by RBS to meet the PRA 7% as of December 2013

Note 4

3.2

0.4

 

 

Note 1: CET1 Basel 3 capital position as of December 2012

Reference

Capital

RWA

%

£bn

£bn

PRA

37.2

567.9

6.5%

Adjustments:

 

- Capital base changes

Note 2

1.0

0.2%

- Counterparty risk IMM model extension

Note 3

(47.0)

0.6%

- Reduction in counterparty risk due to CRDIV CVA changes

Note 3

(36.0)

0.5%

- Other

Note 3

10.1

(0.1)%

RBS (as published)

a

38.2

495

7.7%

 

 

a Note that Deferred Tax Asset deduction is taken in full: with an impact of 70bps on CT1. The real capital benefit of this asset for RBS will emerge over the next 5 years as the Group returns to profitability.

 

 

 

Note 2: The end 2012 capital base variance of £1bn is due to:

 

i) securitisation treated as RWAs rather than a deduction;

ii) offset principally by higher actual provisions taken in Q4 2012 for conduct risk relative to forecast used by the PRA.

 

Note 3: The RWA adjustment of £72.9bn represents RBS assumption around counterparty credit model acceptance that a) brings RBS in line with peers and b) has been worked on for two years with approval expected shortly; and latest CRDIV changes reflected by RBS but not by the PRA given timing of the exercise. In addition, this also includes impact of securitisation treated as RWA rather than a deduction.

Reference

£bn

£bn

 

RWAs per PRA (Dec-12 Flash)

567.9

Counterparty risk IMM model extension

(47.0)

Reduction in counterparty risk due to CRDIV text changes

b

(36.0)

Net Other (including securitisation treated as RWA)

10.1

(72.9)

RWAs - as adjusted

495.0

 

 

Note 4: RBS actions to address remaining gap

Factoring in business plans announced at the FY12 results, Q113 IMS and remaining planned capital actions, RBS's capital shortfall reduces to £0.4bn, which the Group plans to fully satisfy in early 2014.

Reference

Per PRA

Per RBS

£bn

£bn

Total Capital actions required

13.6

7.5

Adjustments for models & EU exemptions

(6.1)

-

7.5

7.5

Q1 2013 progress on fully loaded ratio

(2.4)

Q2-Q4 2013 planned actions

RWA reduction (including Non Core rundown & Markets reshape)

(3.0)

Reduction in excess Expected Loss over provision

(1.0)

Other capital movements

c

(0.7)

Total Q2-Q4 2013 planned actions

(4.7)

Total 2013 actions

(7.1)

Post planned actions capital requirement

d

0.4

 

 

 

b CRDIV final text includes exemption for EU corporates, pension funds and sovereigns from CVA volatility charge in RWA calculations.

cCapital base movement includes, among other things, use of consensus profit forecast, expected gains on small disposals and liability management exercises.

d Remaining gap of £0.4bn to be closed through Q1 2014 profit generation and continuing benefits of Markets re-sizing. Planned IPO of Citizens provides further comfort.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKKDKABKKQAB
Date   Source Headline
22nd Jul 20202:00 pmRNSChange of Name
16th Jul 20207:00 amRNSIntention to Change Name on 22 July 2020
1st Jul 202012:29 pmRNSDirector/PDMR Shareholding
30th Jun 20204:26 pmRNSTotal Voting Rights
29th Jun 20207:00 amRNSNotice of Redemption
25th Jun 20209:19 amRNSRBSG pricing of US$1.5bn Additional Tier 1 Notes
23rd Jun 20207:00 amRNSChanges to the Alternative Remedies Package
11th Jun 20205:31 pmRNSPublication of Supplementary Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
8th Jun 20204:15 pmRNSHolding(s) in Company
8th Jun 20203:38 pmRNSTotal Voting Rights and Capital
8th Jun 20203:20 pmRNSDirector/PDMR Shareholding
29th May 20203:09 pmRNSDirector/PDMR Shareholding
29th May 20202:25 pmRNSTotal Voting Rights
29th May 202012:52 pmRNSDividend Declaration
21st May 202010:15 amRNSAdditional Listing
20th May 20207:04 amRNSRBSG pricing of US$1.6bn of Senior Notes
14th May 20201:00 pmRNSDirector/PDMR Shareholding
13th May 20204:01 pmRNSPublication of Final Terms
12th May 202011:16 amRNSQ1 2020 Pillar 3 Supplement
5th May 20204:57 pmRNSPublication of Supplementary Prospectus
1st May 20204:20 pmRNSPublication of Suppl.Prospcts
1st May 20207:00 amRNSQ1 Interim Management Statement
30th Apr 202012:20 pmRNSTotal Voting Rights
29th Apr 20204:33 pmRNSResult of AGM
29th Apr 20203:01 pmRNSAGM Statement
28th Apr 20203:51 pmRNSDirector/PDMR Shareholding
27th Apr 20204:40 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20203:58 pmRNSDisclosure of rights attached to equity shares
20th Apr 202012:38 pmRNSDividend Declaration
14th Apr 20204:21 pmRNSVirtual Shareholder Event – 29 April 2020
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20202:14 pmRNSBlock Listing Six Monthly Return
3rd Apr 20204:11 pmRNSAmendment of Final Terms
3rd Apr 20203:24 pmRNSNotice of AGM
2nd Apr 202012:11 pmRNSDirector/PDMR Shareholding
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202011:34 amRNSRoyal Bank of Scotland Group
1st Apr 20207:00 amRNSResponse to Covid-19
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.